Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Johnson & Johnson
Johnson & Johnson
Page 11 of 18
Health
J&J’s COVID vaccine could make its global debut as soon as next week
By
David Meyer
February 10, 2021
Health
The AstraZeneca COVID-19 vaccine (and possibly others) are ineffective against the South African variant
By
Jeremy Kahn
February 8, 2021
Health
Johnson & Johnson’s lower-immunity single-dose COVID vaccine might be just what the doctor ordered
By
Kat Eschner
February 1, 2021
Health
Why Europe’s summer COVID vaccination target could still be on track
By
David Meyer
February 1, 2021
Magazine
The companies business leaders admire the most—and are watching closely
By
Matthew Heimer
and
Scott DeCarlo
February 1, 2021
Politics
Johnson & Johnson’s single-dose COVID-19 vaccine is 66% effective, lagging rivals
By
The Associated Press
January 29, 2021
Newsletters
Stocks to watch under a Biden presidency
By
Bernhard Warner
January 26, 2021
Newsletters
Last week’s vaccine-led rally was one for the record books—but is all that good news already priced in?
By
Bernhard Warner
November 16, 2020
Health
The science behind the leading COVID vaccine candidates
By
Sy Mukherjee
November 4, 2020
Newsletters
Not even Big Tech can save investors from the latest markets plunge
By
Bernhard Warner
October 28, 2020
Newsletters
Here’s what could happen to your portfolio in the case of a ‘no deal’ on fiscal stimulus
By
Bernhard Warner
October 21, 2020
Health
As COVID-19 numbers boom and markets tank, Europe’s leaders urge vaccine coordination
By
David Meyer
October 15, 2020
Health
J&J CEO still optimistic COVID-19 vaccine could come as early as this year
By
Robert Hackett
October 14, 2020
Newsletters
Investors pull back on vaccine jitters and earnings woes
By
Bernhard Warner
October 14, 2020
Newsletters
Earnings season is here. Will companies deliver on the hype?
By
Bernhard Warner
October 13, 2020
Most Popular
Real Estate
The 'Great Housing Reset' is coming: Income growth will outpace home-price growth in 2026, Redfin forecasts
By
Nino Paoli
AI
Nvidia CEO says data centers take about 3 years to construct in the U.S., while in China 'they can build a hospital in...
By
Nino Paoli
Economy
The most likely solution to the U.S. debt crisis is severe austerity triggered by a fiscal calamity, former White House...
By
Jason Ma